About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.


The Lausanne University Hospital (CHUV) is one of five Swiss university hospitals. Through its collaboration with the Faculty of Biology and Medicine of the University of Lausanne and the EPFL, CHUV plays a leading role in the areas of medical care, medical research and training. The drug in real life unit is part of the new Centre de Recherche et Innovation en Sciences Pharmaceutiques Cliniques – CRISP. Its research activities focus on how drugs are used once they are on the market and how their use can be improved. | READ MORE >>
The Motherhood Collective Impact program (MCIP) is a not-for-profit partnership that aims to address the most challenging issues in maternal health by taking a new, co-impact and systems-based approach. From 14th - 20th October 2019 they held their annual Safe Motherhood week. The theme of this year was: Accessibility to quality maternal care and safe medication. MCIP spoke with our project leads (Dr. Ida Niklson, (Novartis) & Prof. Dr. Miriam Sturkenboom (UMC Utrecht)) on how ConcePTION will bridge the knowledge gap for pregnant and breastfeeding women. | READ MORE >>
Uppsala Monitoring Centre is the WHO collaborating Centre for International Drug Monitoring with members in more than a network 150 countries. Which profides a global network for pharmacovigilance. In the recent issue of their magazine Reports they focus on the needed search for drug safety facts for pregnant and breastfeeding women with a lengthy interview of two partners of ConcePTION. | READ MORE >>


Having children? We need your help developing a tool for #pregnant and #nursing women with questions about the safety of their drugs before, during and after #pregnancy. Share your experiences by filling out our survey: https://bit.ly/2RvvsbC #maternalhealth

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.


The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.